Playback speed
10 seconds
EULAR® 2024 Insights: Guselkumab Provides Durable Improvements in Pain Among Patients With Psoriatic Arthritis and an Inadequate Response to TNFi: COSMOS Phase 3b Trial
By
EULAR® 2024 Insights
FEATURING
Laura Coates
By
EULAR® 2024 Insights
FEATURING
Laura Coates
48 views
June 21, 2024
Comments 0
Login to view comments.
Click here to Login